Chartwell Investment Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-18,489
Closed -$942K – 414
2020
Q1
$942K Sell
18,489
-20,400
-52% -$1.18M 0.04% 324
2019
Q4
$2.14M Sell
38,889
-34,253
-47% -$1.86M 0.07% 277
2019
Q3
$3.68M Hold
73,142
– – 0.12% 234
2019
Q2
$3.69M Buy
73,142
+3,978
+6% +$193K 0.12% 241
2019
Q1
$3.21M Buy
69,164
+864
+1% +$43.8K 0.1% 262
2018
Q4
$3.35M Buy
68,300
+1,951
+3% +$111K 0.12% 250
2018
Q3
$4.12M Buy
66,349
+85
+0.1% +$5.17K 0.12% 252
2018
Q2
$3.57M Sell
66,264
-2,313
-3% -$116K 0.11% 258
2018
Q1
$3.12M Sell
68,577
-1,126
-2% -$48.3K 0.11% 235
2017
Q4
$2.74M Sell
69,703
-65,252
-48% -$2.48M 0.09% 289
2017
Q3
$4.98M Buy
134,955
+36,684
+37% +$1.31M 0.17% 191
2017
Q2
$3.78M Buy
+98,271
New +$3.6M 0.14% 201

Other funds holding EHC

Chartwell Investment Partners's EHC Position: Q2 2020 in Review

Chartwell Investment Partners sold out of Encompass Health (EHC) in Q2 2020, closing a stake of 18,489 shares — an estimated $942K sold.

Chartwell Investment Partners first reported a position in EHC in Q2 2017 and held it in 12 quarters. The position peaked at $4.98M in Q3 2017. 384 funds tracked by Wall St. Rank hold EHC as of Q2 2020.

  • Chartwell Investment Partners reported no remaining Encompass Health position as of Q2 2020 after selling out during the quarter.
  • Chartwell Investment Partners sold 18,489 Encompass Health shares in Q2 2020, an estimated $942K.
  • Chartwell Investment Partners first reported a position in Encompass Health in Q2 2017 and held it in 12 quarters.
  • Chartwell Investment Partners's Encompass Health position peaked at $4.98M in Q3 2017.
  • 384 funds tracked by Wall St. Rank held Encompass Health as of Q2 2020.

Based on Chartwell Investment Partners's 13F filing for Q2 2020, filed 29 Jul 2020.